World TB day: funding cuts threatening millions of lives
Boosting research capacity through operational training
Calling for action to support women around the world this International Women’s Day
Recommendations released for use of opioid agonist treatment in prisons
Research Reports + Policy Briefs
IMPACT Magazine
Events
Research Articles
How Science Matters Podcast
Study at Burnet
Antimicrobials for Neonates: Practitioner Decisions and Diagnostic Certainty.
Agency in young people’s unsafe abortion trajectories in Papua New Guinea.
Why the Delay? A Quality Improvement Initiative for Delayed Cord Clamping in Pr...
Unpacking diverse pathways to adolescent pregnancy in Cambodia: Qualitative rese...
Vaccines
Diagnostics
Therapeutics
Antibody Platforms
Australia
Papua New Guinea
Myanmar
People of Burnet
Leadership
Burnet Partners
Board Members
Appeals
Monthly Giving
Trusts + Foundations
Corporate Supporters
Giving in Wills + Bequests
Supporter Stories
About Us
Careers
History
Annual + Financial Reports
Burnet Institute is developing platforms to enhance efficacy of antibodies, Fc-fusion proteins, and antibody-like biologics that have potential application in oncology, infectious disease and immunological conditions.
Find us at BIO 2024 this June.
A hexamerising technology that transforms the potency of monoclonal antibodies (mAb), Fc fusion prot...
